BMY has been in the news 353% more than usual
Oct 28, 2025, 10:32 PM
15.00%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: Bristol Myers Squibb Company is not directly mentioned in the provided information. However, it is noteworthy that the biopharmaceutical industry is experiencing significant mergers and advancements, such as Avidity Biosciences' $12 billion merger with Novartis AG. Additionally, competitors like Eli Lilly & Co. are expected to report strong earnings due to the success of their drugs, highlighting the dynamic nature of the sector.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.